Smart jab can shrink head and neck cancer tumours within six weeks, trial finds
Triple-action therapy drug amivantamab could be given as an injection to help treat recurrent or metastatic cancers Doctors have hailed “incredibly encouraging” trial results that show a triple-action smart jab can shrink tumours in head and neck cancer patients within six weeks. Head and neck (…)
Site référencé:
The Guardian
3566.jpg?width=140&quality=85&auto=format&fit=max&s=6b8d8aa1d243e52630ec912240d7c64f, 3566.jpg?width=460&quality=85&auto=format&fit=max&s=2d87713509e54a6825bcd7efa979683a, 3566.jpg?width=700&quality=85&auto=format&fit=max&s=0f55e3e23cd4fdddf1f92afd52d64c83
The Guardian
Regulators overlooking toxic Pfas found around Lancashire chemicals plant
19/10/2025
TV tonight : the upbeat Star Trek prequel with a fresh-faced Spock
19/10/2025
The ‘enormous conflict of interest’ at centre of Jared Kushner’s Gaza ceasefire deal
19/10/2025
‘Why are our black boys hurting each other ?’ Letitia Wright on the deaths that inspired her directorial debut
19/10/2025
670 Grams, Birmingham B9 : ‘A cascade of small, meaningful bowls that just ooze flavour’ – restaurant review | Grace Dent on restaurants
19/10/2025
The return of ‘Tescopoly’ ? How Britain’s biggest retailer dominates everyday life
19/10/2025